Literature DB >> 19914200

Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus.

Jeremy A Hengst1, Jacquelyn M Guilford, Elizabeth J Conroy, Xujun Wang, Jong K Yun.   

Abstract

Sphingosine kinase 1 (SphK1) responds to a variety of growth factor signals by increasing catalytic activity as it translocates to the plasma membrane (PM). Several studies have identified amino acids residues involved in translocation yet how SphK1 increases its catalytic activity remains to be elucidated. Herein, we report that deletion of 21 amino acids from the COOH-terminus of SphK1 (1-363) results in increased catalytic activity relative to wild-type SphK1 (1-384) which is independent of the phosphorylation state of Serine 225 and PMA stimulation. Importantly, HEK293 cells stably expressing the 1-363 protein exhibit enhanced cell growth under serum-deprived cell culture conditions. Together the evidence indicates that the COOH-terminal region of SphK1 encompasses a structural element that is necessary for the increase in catalytic activity in response to PMA treatment and that its deletion renders SphK1 constitutively active with respect to PMA treatment. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914200      PMCID: PMC2812673          DOI: 10.1016/j.abb.2009.11.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  45 in total

1.  Cascaded multiple classifiers for secondary structure prediction.

Authors:  M Ouali; R D King
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

2.  A method for quantitative extraction of sphingosine 1-phosphate into organic solvent.

Authors:  S F Kralik; X Du; C Patel; J P Walsh
Journal:  Anal Biochem       Date:  2001-07-15       Impact factor: 3.365

3.  A point mutant of human sphingosine kinase 1 with increased catalytic activity.

Authors:  S M Pitson; P A Moretti; J R Zebol; M A Vadas; R J D'Andrea; B W Wattenberg
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

4.  Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors.

Authors:  D Meyer zu Heringdorf; H Lass; I Kuchar; M Lipinski; R Alemany; U Rümenapp; K H Jakobs
Journal:  Eur J Pharmacol       Date:  2001-03-02       Impact factor: 4.432

5.  Functional characterization of human sphingosine kinase-1.

Authors:  V E Nava; E Lacana; S Poulton; H Liu; M Sugiura; K Kono; S Milstien; T Kohama; S Spiegel
Journal:  FEBS Lett       Date:  2000-05-04       Impact factor: 4.124

6.  Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes.

Authors:  S M Pitson; R J D'andrea; L Vandeleur; P A Moretti; P Xia; J R Gamble; M A Vadas; B W Wattenberg
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

7.  Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling.

Authors:  Pu Xia; Lijun Wang; Paul A B Moretti; Nathaniel Albanese; Fugui Chai; Stuart M Pitson; Richard J D'Andrea; Jennifer R Gamble; Mathew A Vadas
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

8.  PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA).

Authors:  Korey R Johnson; Kevin P Becker; Maria Marta Facchinetti; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2002-07-17       Impact factor: 5.157

Review 9.  The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction?

Authors:  Mathew Vadas; Pu Xia; Geoff McCaughan; Jennifer Gamble
Journal:  Biochim Biophys Acta       Date:  2008-06-27

Review 10.  Sphingolipid metabolizing enzymes as novel therapeutic targets.

Authors:  Andreas Billich; Thomas Baumruker
Journal:  Subcell Biochem       Date:  2008
View more
  7 in total

1.  Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.

Authors:  F Ali-Rahmani; J A Hengst; J R Connor; C-L Schengrund
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

2.  An intrinsic lipid-binding interface controls sphingosine kinase 1 function.

Authors:  Michael J Pulkoski-Gross; Meredith L Jenkins; Jean-Philip Truman; Mohamed F Salama; Christopher J Clarke; John E Burke; Yusuf A Hannun; Lina M Obeid
Journal:  J Lipid Res       Date:  2018-01-11       Impact factor: 5.922

3.  Targeting sphingosine kinase-1 to inhibit melanoma.

Authors:  SubbaRao V Madhunapantula; Jeremy Hengst; Raghavendra Gowda; Todd E Fox; Jong K Yun; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2012-03       Impact factor: 4.693

4.  Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.

Authors:  Jeremy A Hengst; Shailaja Hegde; Robert F Paulson; Jong K Yun
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

5.  Localized sphingolipid signaling at presynaptic terminals is regulated by calcium influx and promotes recruitment of priming factors.

Authors:  Jason P Chan; Derek Sieburth
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

6.  A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells.

Authors:  Ryan D R Brown; Ben E P Veerman; Jeongah Oh; Rothwelle J Tate; Federico Torta; Margaret R Cunningham; David R Adams; Susan Pyne; Nigel J Pyne
Journal:  J Biol Chem       Date:  2021-04-15       Impact factor: 5.157

7.  The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC.

Authors:  Cheng-Fan Lee; Yu-An Chen; Elizabeth Hernandez; Rey-Chen Pong; Shihong Ma; Mia Hofstad; Payal Kapur; Haiyen Zhau; Leland Wk Chung; Chih-Ho Lai; Ho Lin; Ming-Shyue Lee; Ganesh V Raj; Jer-Tsong Hsieh
Journal:  Clin Transl Med       Date:  2022-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.